The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Ironic that a labour shortage should be blamed for problems at a company specialising in robotic stock-picking but that's what they say - a shortage of drivers, however. What could be causing that? Weird times.
At the moment, all my winners are value stocks, making profits and paying dividends. The brave thing to do would be to sell them and buy unpopular risky growth stocks but I am not that brave.. I'll just hang on in here with what I have got.
Today:
"Diploma is a key industrial play, says Berenberg
Industrial machinery group Diploma (DPLM) reported a record 2021 and Berenberg believes it can deliver more this year.
Analyst Joseph Bloomfield retained his ‘buy’ recommendation and increased the target price from £31.50 to £32 on the stock, which closed down 2.5% at £27.74 on Friday.
The group reported a record 2021, with revenue up 46% year-on-year and 2022 has ‘started strongly for the company too’ with first-quarter revenue growth of 16% and operating margin guidance of 18-19% maintained despite inflationary pressures.
‘While management is guiding to first half-weighted growth for 2022, we expect the demand outlook to remain bright throughout the year,’ said Bloomfield.
‘We continue to view Diploma as a key “buy” idea in the UK industrials sector, with the shares down by 22% from highs, trading on 29x 2023 earnings.’"
Went for it. I like the news late last year that MNG got the green light to sell legacy assets for >£10bn after it was initially blocked. Price is now 70p over my average sp but MNG but the management look competent and ambitious IMO.
The exceptionally low P/E ratio suggests that a certain amount of risk has been priced in. Quite a lot of risk. The management are also aware that they can’t afford to look like a one-truck pony and are diversifying.
Agree that 2022 is a bit of a darkened room at the moment and no sign of the lights being turned on but business will go on.
Trian expected to revive its P&G playbook with Unilever
https://finance.yahoo.com/amphtml/news/trian-expected-revive-p-g-143520754.html
So the price drops. Just what I was looking for. I can't find any worse news! Might be time to get back in..
https://www.lse.co.uk/news/DPLM/diploma-ytd-underlying-revenues-grow-g1dv7iieskhdz5z.html
Fool says it's a good opportunity to buy both GSK and ULVR. Just took some profits from GSK however and I don't think ULVR is a ripe buy at the moment. The bid looked too much like a desperate measure to me.